stars 1 stars 2 stars 3

The Medicines Evaluation Unit (MEU) Ltd, an IQVIA business, is one of the UK’s leading contract research organisations, a facility where commitment to excellence is paramount. Possessing extensive pharmaceutical, scientific and clinical expertise, within a state-of-the-art hospital-based research facility, allied with fast volunteer recruitment rates, enables MEU to offer clients positive clinical trial solutions. The MEU’s core skill area is in respiratory clinical trials, together with early phase exploratory studies. This is enhanced by the specialist support offered by collaboration with the University Hospital of South Manchester, and its extensive facilities. The MEU specialises in performing clinical trials (from Phase I through to IV) in respiratory / inflammatory medicine and related areas.

Medicines Evaluation Unit Ltd Questions

The Medicines Evaluation Unit Ltd annual revenue was $8.4 million in 2026.

David Rogers is the CEO of Medicines Evaluation Unit Ltd.

80 people are employed at Medicines Evaluation Unit Ltd.

The NAICS codes for Medicines Evaluation Unit Ltd are [3254, 325, 32541, 32].

The SIC codes for Medicines Evaluation Unit Ltd are [283, 28].

Top Medicines Evaluation Unit Ltd Employees

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users